European Journal of Hematology
Fecha de publicación: 15 July 2019
DOI: https://doi.org/10.1111/ejh.13293
Autores: Michael Lauseker, Roman Gerlach, Wenke Worseg, Torsten Haferlach, Martin Tauscher, Joerg Hasford, Verena S. Hoffmann
Background: There are established guidelines for treatment and monitoring of chronic myeloid leukemia (CML) but little is known about routine care. Data on ICD‐10 codes as well as prescribed medications were available for 10.5 million patients in the statutory health insurance system in Bavaria for the years 2010 to 2016.
Leer más
Comentarios
Para dejar un comentario antes debes iniciar sesión:
¿No tienes una cuenta?
Regístrate a través de éste enlace.